During the past decade, National Institute of Oncology and Radiobiology (INOR) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "National Institute of Oncology and Radiobiology (INOR)" are "Adnexal Diseases" (1 trials), "Carcinoma" (1 trials), "Colonic Diseases" (1 trials), "Colorectal Neoplasm" (1 trials) and "Digestive System Disease" (1 trials). Many other conditions were trialed in "National Institute of Oncology and Radiobiology (INOR)" in a lesser frequency.

Most popular intervention types in "National Institute of Oncology and Radiobiology (INOR)" are "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocoxin-Viusid" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Oncology and Radiobiology (INOR)" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "National Institute of Oncology and Radiobiology (INOR)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in National Institute of Oncology and Radiobiology (INOR), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Oncology and Radiobiology (INOR), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".